NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Visano Theranostics

Visano Theranostics

Private
Fairview Park, OhioHealthcare & Life Scienceshttps://visanotheranostics.com/

Last Round

Seed

Jan 8, 2026

Total Funding Raised

$445,000

Company Overview

Visano Theranostics is a biotechnology company developing next-generation nanobubble ultrasound contrast agents for the precise diagnosis and treatment of prostate cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

ultrasound contrast agentprostate cancer diagnosisnanobubble technologytheranosticsPSMA-targetedprostate biopsymolecular imagingtransrectal ultrasoundTRUStargeted nanobubble therapyTNTimage-guided therapycontrast-enhanced ultrasoundCEUSmedtech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Visano Theranostics Comparables

Compare Visano Theranostics with similar companies based on industry and business-model similarity.

Visano Theranostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bracco S.p.A.
63%
Apeikon Therapeutics
63%
Microvascular Therapeutics, Inc.
63%

Visano Theranostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 8, 2026
AcceleratorOct 1, 2025
GrantJul 22, 2025

Visano Theranostics Investors

Notable investors and investment history

Visano Theranostics investors
InvestorRounds
Ohio Third Frontier CommissionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2025

    $170K grant received from Ohio Third Frontier Commission.

Visano Theranostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Visano Theranostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Visano Theranostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersFairview Park, Ohio
Year Founded2024
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.